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Abstract 
Bloodborne pathogens are all around us, yet we seldom think about them. Exploring the who, 
what, when, where, and why aspects of bloodborne pathogens allows to develop a better 
comprehension of the world we live in and how to protect and prevent the spread of infectious 
disease. Human Immunodeficiency Virus (HIV), hepatitis B virus (HBV), and hepatitis C virus 
(HCV) are the top three bloodborne pathogens and the main focus of this entry. This article is 
designed to be easy to read and readily understood in order to appeal to a much broader range of 
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Introduction 
In accordance with the Occupational Safety and Health Administration (OSHA), 
bloodborne pathogens are defined as “infectious microorganisms in human blood that can cause 
disease in humans” (OSHA, n.d., paragraph 1). The American Red Cross states that “bloodborne 
pathogens, such as bacteria and viruses, are present in blood and body fluids and can cause 
disease in humans” (The American National Red Cross, 2011, p.1).  Human immunodeficiency 
virus, more commonly known as HIV, affects an estimated 34 million people worldwide. 
Worldwide, an estimated 350 million people have hepatitis B and, 150-350 million individuals 
are infected with hepatitis C (Department of Health and Human Services, 2010). While these 
numbers are astonishing, it is disappointing to know that there are a large number of those 
infections that could have been prevented. Individually, the three infectious diseases mentioned 
are recognized, but when grouped into a unit, what are they? The Occupational Safety and 
Health Association (OSHA) defines them as bloodborne pathogens. The purpose of this paper is 
to discuss the most common bloodborne pathogens in the United States, the signs and symptoms 
associated with the pathogens, those at greater risk for acquiring the pathogens, and preventative 
measures. Bloodborne pathogens are be taken seriously but not feared; therefore, education on 
this is essential to improve the understanding of this topic and reduce the incidences of the 
disease.  
Human Immunodeficiency Virus (HIV) 
What: 
“Human immunodeficiency virus (HIV) is a viral infection that weakens the immune 
system and is a subsequent causative agent of acquired immunodeficiency syndrome (AIDS).  
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The virus is transmitted through the exchange of a variety of bodily fluids mainly sexually, 
perinatal, and blood-borne. HIV/AIDS is one of the highest contributor to morbidity, and it is the 
sixth leading cause of mortality worldwide” (Rumbwere, Dube, Marshall, & Ryan, 2016, p.1).  
The Center for Disease Control and Prevention (CDC) estimated that in 2014 the United States 
alone had approximately 1.1 million individuals infected with HIV. Sadly, of that 1.1 million, 
15% did not know they had been infected with HIV. In the year 2015, an astonishing 39,513 
individuals were newly diagnosed with HIV in the U.S. alone. While this is a 9% decrease from 
2010 it is still a large number, that in some instances, could have been prevented. This virus does 
not discriminate. It does not care about sex, race, or ethnicity. The virus does not care where you 
live or what kind of car you drive. It does not care how pretty you are or how well kept you 
consider yourself.  
Who: 
Although it does not pick its victims, it is prevalent within certain demographics and 
weighs heavily on certain lifestyles. It’s only target for potential candidates are those who place 
themselves in the way of risky behaviors and chose to not take necessary precautions to protect 
themselves.   In 2014 reports indicate that male to male sexual contact accounted for 70% of new 
diagnoses with 45% of those males being African American (Center for Disease Control and 
Prevention, 2017). This is, of course, not without a cause like most things, there is one exception 
and that is a child who contracted the virus via mother’s womb. Obviously, while the mother’s 
risky behavior unfortunately jeopardized the unborn baby, that is not the child’s fault, so that is 
exempt from the previous statement. “In 2014, an estimated 2,477 children aged <13 years were 
living with diagnosed human immunodeficiency virus (HIV) infection in the United States” 
(Tanner, Bush, Nesheim, et al, 2017, pg. 1033). 
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“Estimates suggest that over 16 million people worldwide inject drugs and 3 million of 
those people are infected with HIV” (DARA Thailand, 2017, paragraph 5). That is a pretty stout 
number and should leave an impression. While there are programs that are established in order to 
decrease the amount of “dirty needles” on the streets, they are still in play and still affect those in 
their path. Recreational drug use has become an increasingly dominant trend over the years and 
that reflects in the increased number of patients diagnosed with HIV, not to mention those who 
have not been tested and placed on some sort of treatment therapy in order to reduce 
transmission. Many states, including but not limited to Kentucky, have pieces of legislation in 
place protecting those who come in contact with individuals who have HIV or AIDS and do not 
disclose that information before risky behaviors occur.  
In 2014 there were an estimated 6,511 people living with diagnosed HIV in Kentucky. By 
the end of 2014, the mortality rate for the year was 112 individuals. Unfortunately, by 2015 there 
were an added 336 newly diagnosed cases of HIV. Kentucky statistics show that of the 6,511, 
80% were men and 20% were women, along with 56% being of the Caucasian race, 33% black, 
and 6% Hispanic/Latino. 27.2% of Kentuckians will be diagnosed with AIDS within three 
months of the initial HIV diagnosis (AIDSVu, n.d.). 
“CDC’s National HIV Behavioral Surveillance (NHBS) monitors behaviors among 
populations at risk for acquiring or transmitting HIV infection. Recent NHBS data indicate that 
persons at risk for HIV infection who had ever received testing for HIV are testing at shorter 
intervals than in the past. The average interval in months between two successive HIV tests 
decreased from 21.1 in 2010 to 19.9 in 2013 among heterosexuals at increased risk for HIV, 
from 10.5 in 2009 to 7.7 in 2014 among men who have sex with men, and from 14.4 in 2009 to 
11.5 in 2015 among persons who inject drugs” (Stein, Song, et al, 2017, pg. 629). 
BLOODBORNE PATHOGENS: THE FIVE W’S  6 
When: 
Statistics show that “Gay and bisexual men have the largest number of new diagnoses in 
the United States” (U.S. Department of Health and Human Services, 2017, paragraph 4). Also, 
transgender women who have sex with men are among the groups at highest risk for HIV 
infection. Anal sex is the highest-risk sexual behavior. Individuals who are HIV negative and 
being a receptive partner (or bottom) for anal sex is the highest-risk sexual activity for getting 
HIV. The Center for Disease Control and Prevention reports that anal sex is a high-risk behavior 
due to “the lining of the rectum is thin and may allow HIV to enter the body during anal sex” 
(2017, paragraph 2). Being HIV positive and being the insertive partner (or top) for anal sex is 
the highest-risk sexual activity for transmitting HIV (U.S. Department of Health and Human 
Services, 2017). Research and statistics related to HIV can be found in every media outlet. Even 
with risk factors of contracting and transmitting HIV known, there are still huge numbers of new 
cases. Why is there an increase in these rates? One reason is that some people are either 
uneducated on protection or they are too proud to admit that they do practice high-risk behaviors 
they could put them at risk for contracting HIV. Many have the mentality that “it won’t happen 
to me” and that is an inaccurate statement to assume. There are too many variables that could 
make those individuals susceptible to the virus including but not limited to, just down right 
unfaithfulness between partners and lack of honesty between partners.  
Why: 
Preventative measures and education are imperative in order to achieve a steady decrease 
in HIV. Human immunodeficiency virus is defined as a virus spread through certain body fluids 
that attacks the body’s immune system, specifically the CD4 cells, often called T4 cells 
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(HIV.gov, 2017). This infection is acquired through blood and bodily fluids inhibits the body’s 
natural immune system to fight off the disease can in turn result in the development of AIDS 
(acquired immunodeficiency syndrome). AIDS is the most severe stage of HIV and results in the 
infected patient being highly susceptible to opportunistic infections, or simple, severe illness. At 
this point, the immune system is so greatly damaged there is no way to reverse the damage. HIV 
is irrevocable, once acquired, it may be controlled with medicine but will not dissipate or be 
cured.  
In beginning stages, HIV often mimics flu like symptoms, and many times that is exactly 
what the infected individual thinks is going on. Symptoms such as fever, body aches, sore throat 
and rashes are a few of the experienced symptoms generally within the first two to four weeks of 
exposure (HIV.gov, 2017). This is considered to be an acute phase or stage of the virus and it is 
crucial to be seen by a physician at this point to decrease the chances of further damage.  It is 
also the most likely time to transmit the HIV to a sexual partner or between individuals who 
share needles, as this is when the highest production of the virus occurs within the body. “During 
this early period of infection, large amounts of virus are being produced in your body. The virus 
uses CD4 cells to replicate and destroys them in the process. Because of this, CD4 cells can fall 
rapidly. Eventually the immune response will begin to bring the level of virus in the body back 
down to a level called a viral set point, which is a relatively stable level of virus in the body. At 
this point, the CD4 count begins to increase, but it may not return to pre-infection levels. It may 
be particularly beneficial to personal health to begin ART during this stage” (HIV.gov, 2017, 
paragraph 9). Doctors original treatment approach to HIV and AIDS was focused on “prevention 
strategies and treatment of symptomatic diseases, but due to the benefits of ART, the emphasis 
has now moved to earlier HIV diagnosis” (Rumbwere Dube, B.N., Marshall, T.P., Ryan, R.P., 
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2016, p.1-2). Early detection helps to keep irreversible damage from occurring and to inhibit the 
transition of HIV to AIDS. The screening process along with the treatment regimen have both 
gotten increasingly better over the years. 
 Scientific development has made huge strides in increasing availability of antiretroviral 
therapy (ART) and more cost-efficient pharmaceuticals to slow and even halt the progress of 
HIV.  Antiretroviral therapy, when taken in combinations, is currently the most effective form of 
treatment available for HIV patients. The wording “combinations” denotes this form of drug 
therapy is better when taken in approximately groups of threes versus a monotherapeutic 
approach of one form of antiretroviral therapy drug alone (Thompson, G. and Shalit, P., 2014). 
This medication, when taken properly in conjunction with living a healthy lifestyle can enable an 
individual to live a long life while also decreasing the chances of infecting others (HIV.gov, 
2017).  
Where: 
There are many ways to decrease the likelihood that human immunodeficiency virus will 
be spread but it is up to those participating in risky behaviors to put those preventative methods 
into practice. The practice of using condoms will greatly decrease chances of contracting or 
transmitting HIV, while it is not 100% it is very close. It is imperative when using condoms that 
the condom itself is properly cared for, and that they are kept stored in the proper environment 
that is cool and dry (Center for Disease Control and Prevention, 2017). The only guaranteed way 
to 100% prevent contracting or transmitting HIV is to abstain. Abstinence is defined as someone 
that has never had sex or those that have had sex in the past but chose to stop for an extended 
amount of time. Limiting the number of sexual partners also plays a role in lessening exposure to 
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HIV. The more sexual partners an individual has, the greater the risk of coming into contact with 
someone with a HIV viral load that is not suppressed, leaving that individual with a greater 
chance of contracting the virus (Center for Disease Control and Prevention, 2017).  Preventative 
measures and education are imperative in order to achieve a steady decrease in statistical analysis 
of HIV.  
Hepatitis B Virus (HBV) 
What: 
 With over two billion individuals affected worldwide and taking the rank at the tenth 
leading cause of death, Hepatitis B virus has wrecked its havoc. According to the National 
Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the definition of hepatitis B 
virus is a “viral infection that causes liver inflammation and damage. Inflammation is swelling 
that occurs when tissues of the body become injured or infected. Viruses invade normal cells in 
your body. Many viruses cause infection that can be spread from person to person. The hepatitis 
B virus spreads through contact with an infected person’s blood, semen, or other body fluids” 
(National Institute of Diabetes and Digestive and Kidney Disease, 2017, paragraph 1).  
 Hepatitis B virus is highly common and very contagious. “Researchers estimate that 
about 850,000 to 2.2 million people in the United States have chronic hepatitis B” (National 
Institute of Diabetes and Digestive and Kidney Disease, 2017, paragraph 7).  
Who: 
 Sadly, the most common individual subjected to hepatitis B virus are innocent infants. 
Those who are born to mothers who have the virus are the most likely to contract hepatitis B 
virus, with most of those being born in countries with high HBV rates or infants born in the 
United States who were unvaccinated and have parents who were born in an area with high HBV 
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rates. “In the United States, 47 to 95 percent of people with chronic hepatitis B were born outside 
the United States, in parts of the world where hepatitis B is more common” (National Institute of 
Diabetes and Digestive and Kidney Disease, 2017, paragraph 8).    
 “In the United States, sexual contact is the most common way that hepatitis B spreads 
among adults. Injection drug use is another important way that hepatitis B spreads. Since 2009, 
the number of acute hepatitis B infections has risen in some Appalachian states, especially 
among adults who inject drugs” (National Institute of Diabetes and Digestive and Kidney 
Disease, 2017, paragraph 9). Individuals residing in the prison system are also at a large risk of 
contracting hepatitis B virus. “Globally, there are more than 10 million people in prison at any 
one time, and a significant portion of these are at risk of acquiring or transmitting hepatitis B 
infection” (Society for the Study of Addiction, 2010, pg. 189). 
When: 
There are multiple vectors of transmission making it wide spread. HBV is in blood, 
semen, saliva, vaginal secretions, menstrual secretions, and to a lesser extent in breast milk, 
sweat, tears, and urine of infected individuals (Lavanchy, 2004). This leaves a fairly large door 
open for opportunities of transmission from person to person. Although one of the most common 
modes of transmission is invitro, from mother to unborn child through utero. Generally, this 
occurs in areas with large concentrations of the hepatitis B virus infection, most often outside of 
the United States. Also, the infection can occur in infants born in the United States who were 
unvaccinated with parents who were from an area where hepatitis B was common (National 
Institute of Diabetes and Digestive and Kidney Disease, 2017). “About 90 percent of infants 
infected with hepatitis B develop a chronic infection. About 25 to 50 percent of children infected 
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between the ages of 1 and 5 years develop chronic infections” (National Institute of Diabetes and 
Digestive and Kidney Disease, 2017, paragraph 6).  
Because of the resilience of the hepatitis B virus, prisons are a thriving environment for 
the transmission of the virus. “Prisons are a special environment where there are very high 
concentrations of injecting drug users, some of whom continue to inject and share within the 
prison setting. When such prisoners do continue to inject, they are more likely to engage in 
riskier practices and hence are at particular risk of blood-borne virus transmission” (Society for 
the Study of Addiction, 2010, pg. 189). Unlike HIV, hepatitis B is very resilient making it 
capable of living outside the body but, very similarly to HIV, HBV can be transmitted in the 
same ways. In fact, another risk factor is if someone already has HIV, they are at a greater risk of 
contracting hepatitis B virus. 
Why: 
 The hepatitis B virus infection causes extensive damage to internal organs resulting in 
extensive and costly health issues. Once the body begins to detect hepatitis B virus antigens 
(HBeAg) it goes into war mode. The body’s first response system calls warriors into action in 
attempt to ride the body naturally of the infectious virus and the presenting patient’s immune 
system kicks into over drive. This causes the patient’s ALT (alanine aminotransferase) levels to 
begin elevating, this enzyme is one of several referred to as a liver enzyme. At this point, either 
the patient will clean their body of HBeAg, resulting in antibodies (anti-HBe antibodies) that are 
undetectable or of very low detection of the hepatitis B virus. If that does not occur, the ALT and 
anti-HBe antibody levels will continue to rise resulting in chronic hepatitis B virus infection.  In 
this case, a treatment plan would be organized and initiated to allow for the best continuity of 
patient care.  
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 Treatments have been the subject of research for quite some time, and in 2009 there was 
a release of new revelation in therapeutic drugs for treatment of HBV. “Bases on these new 
findings, the recommendation for first-line oral antiviral medications has been changed to 
tenofovir or entecavir, and adefovir has been moved to second-line oral antiviral medication. 
Interferon remains one of the first-line options for patients who do not have cirrhosis” (Lok & 
McMahon, 2009, p.661). While there are other treatments available, not all are globally 
accepted. Interferon (conventional alpha) and lamivudine are currently the only two available for 
global use. Adefovir dipivoxil has been approved for use in the United States and Europe as of 
now (Lavanchy, 2004).  
Where: 
The economic burden of Hepatitis B is significant due to a high death rate. In 2004, 1.25 
million people were chronic HBV carriers. Sadly, most of these were immigrants from areas of 
high HBV concentration. One study showed that during the first seven months health care costs 
were 3.3 times higher in those with chronic Hepatitis B than those of the control (Lavanchy, 
2004). Because of this, vaccinations have played a huge role in treatment as well as reconciling 
cost effectiveness. The prevention that the Hepatitis B vaccination provides is critical in 
decreasing the number of individuals diagnosed with the virus. In return, this allows for lower 
health care costs in the war against HBV and liver failure. 
Vaccination was originally introduced to Asia in 1984 to the babies of mothers with 
known HBV. This process went on for a couple years then began being extended to all newborn 
babies and children of pre-school age who had not been vaccinated (Lavanchy, 2004). While the 
vaccination was introduced slowly into the general public, it has made a significant impact and 
statistics show decreasing numbers of individuals diagnosed with HBV as a result. Since 1991 
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the United States has seen an 82% decrease in new cases of hepatitis B due to doctor’s 
recommendation of U.S. children to receive the hepatitis B vaccine (National Institute of 
Diabetes and Digestive and Kidney Disease, 2017).  “Vaccination is the most effective tool in 
preventing the transmission of HBV infection. Strategies targeting just high-risk groups cannot 
control HBV infection throughout the population. Broader vaccination programs are required 
including infants, children, health care workers, and pregnant women” (Lavanchy, 2004, p.103).  
Hepatitis C Virus (HCV) 
What: 
 As with hepatitis B virus, hepatitis C virus is a viral infectious disease that leads to 
inflammation of the liver. Hepatitis C Virus is currently the most common bloodborne pathogen 
in the United States with new cases arising routinely (Bureau of HIV, STD, and Hepatitis, 2017). 
The Mayo Clinic states that hepatitis C spreads through contaminated blood, and was once felt to 
be treatable but not curable. Now studies have proven HCV to be a curable disease under most 
circumstances (Mayo Clinic, 20017). This viral infection can lay dormant for several years and 
may take a long time for an individual to even know they have it. 
Who: 
To date the largest group of people at risk of HCV are the “baby boomers” those born 
between 1945 and 1965. “While anyone can get Hepatitis C, more than 53% of adults diagnosed 
with HCV in 2016 are baby boomers” (Bureau of HIV, STD, and Hepatitis, 2017, p.1). It is 
unclear as to why this population has the highest rate of hepatitis C virus, but it is speculated to 
be because this time frame was before blood products were thoroughly examined before given. 
Also, these dates were before the development and implementation of universal precautions. It is 
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thought that most baby boomers, at this point, have lived with hepatitis C virus for 20 to 40 years 
(Bureau of HIV, STD and Hepatitis, 2017). In conjunction with baby boomers, studies show that 
most newly acquired infections in the United States are among 30-35-year-old young adults.  
When:  
While baby boomers are the largest demographic group affected by the infectious virus, 
they are hardly the only ones at risk. Obviously, those who have repeated exposure or large 
amounts of exposure to blood from individuals positive for hepatitis C virus are at the greatest 
risk of contraction. For example, those who have received blood transfusions and/or blood 
products, as well as those who have a history or current use of sharing needles through drug 
abuse (injection drug use) are at a higher risk of developing hepatitis C (Mayo Clinic, 2017). 
“Fewer sharing partners are necessary to sustain HCV transmission than are necessary for other 
bloodborne viruses, and indirect drug sharing and preparation practices, such as backloading and 
sharing cotton, cooker, and rinse water, have been associated with HCV transmissions” all of 
which pertain to illicit drug use (Atler, 2007, p. 2438).  Other examples of those at risk for 
hepatitis C virus include, anyone who has received a tattoo or piercing in an unprofessional 
manner. In addition to, any child born to a mother positive for hepatitis C virus and any 
healthcare workers exposed to infected blood are at risk. As well as, anyone who is currently 
HIV positive and anyone who has been in the prison system are at a greater risk of contracting 
hepatitis C. Finally, anyone who has had multiple sexual partners puts themselves in a position 
for highly probable repeated exposure to hepatitis C virus increasing risks of falling victim to the 
infectious disease. Although, these risk factors do not guarantee the virus is present, it highly 
increases the chances of transmission.  
Why: 
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Hepatitis has serious implication when left untreated but unfortunately, most people that 
have HCV are undiagnosed and untreated. There are many symptoms including, extreme 
tiredness, yellowish discoloration of skin and whites of eyes, easy bruising, weight loss, 
confusion, swelling, and easy bleeding to name a few. Keep in mind that Hepatitis C Virus 
infection is a silent killer as it can lay asymptomatic and dormant for years, even up to decades 
before prevailing. Due to the chronic nature of this virus, when signs and symptoms present, it is 
usually related to the extensive liver damage that is already taken place because of the hepatitis C 
virus. “Every chronic hepatitis C infection starts with an acute phase. Acute hepatitis C usually 
goes undiagnosed because it rarely causes symptoms” (Mayo Clinic, 2017, paragraph 5). There 
have been cases of spontaneous viral clearance where acute HCV did not turn chronic due to the 
body’s own ability to fight off or absorb the virial infection.  
While Hepatitis C virus has the potential to lay dormant for several years, generally 
symptoms in the acute phase of the virus appear one to three months after exposure. These 
symptoms tend to only stay present for a few weeks to months before turning chronic or the rare 
occasion the body wards off the virus on its own. “For some people, hepatitis c is a short-term 
illness but for 70%-85% of people who become infected with Hepatitis C, it becomes a long-
term, chronic infection” (Center for Disease Control and Prevention, 2015, paragraph 1). 
 There are different genotypes, or distinct forms, of Hepatitis C Virus and treatment is 
dependent of the specific genotype. There are currently six different genotypes that have been 
identified. These six genotypes are geographically distributed throughout the globe. “HCV types 
1 and 2 have been found in almost all countries tested, including those in Europe, North 
America, and the Far East. Although HCV type 3 has not been found in Japan, it has frequently 
been reported from Europe, Thailand, and India. In the Middle East, almost all anti-HCV-
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positive individuals identified on blood donor screening are infected with type 4, which has also 
been detected in NANBH patients in Zaire. HCV types 5 and 6 show highly restricted 
geographical distributions, being apparently confined to South Africa and Hong Kong 
respectively” (Simmonds, et., 1993, p. 2397).  
Where: 
In terms of distribution of the virus geographically, hepatitis c virus is universal. It is 
present all over the world leaving some statistics unfulfilled because of remote areas inability to 
provide information. In some regions, it is noted that a pattern of transmission occurred in the 
last 20 to 40 years prevailing among young adults. In contrast, other regions show a pattern of 
steady increase with age primarily 50 years of age and older. An exception to both of these is 
Egypt. Egypt shows an increase with age and an overall increase among the general population. 
This not only indicates a risk in the distant past but also an ongoing persistence in transmission 
even though recently acquired HCV can be difficult to detect due to being asymptomatic. On a 
positive note, the United States has shown a drastic decline in hepatitis C virus reporting in at 
greater than 80% since 1989, with Italy’s rate also showing steady declines (Atler, 2007).   
According to the Mayo Clinic, only about 45% of patient treated with standard, antiviral 
therapy for hepatitis c virus are cured of the infection. Currently, there are 40 new treatments 
being explored and two of those will be released this year. The older treatments, Interferon and 
Ribavirin, cue the individual immune system to attack the hepatitis c virus, while new treatments 
are attacking the virus itself head on with only minimal side effects to the individual taking them. 
They are also projected to increase the success rate from 45% to 70%.  
Universal Precautions and other Prevention Methods 
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 Universal precautions are an effort in making advances towards infection control. The 
idea behind universal precautions is to treat all blood and body fluids as if they are infected with 
any bloodborne pathogen. The process was created by the Center for Disease Control and 
Prevention in August of 1987. It was initially developed as a set of guidelines or procedures “to 
prevent parenteral, mucus membrane, and nonintact skin exposures of health care workers to 
bloodborne pathogens” (Farlex Partner Medical Dictionary, 2012, paragraph 1).  
From a health care perspective, it is very important to maintain a good supply of personal 
protective equipment (PPE) and to utilize it accordingly in order to achieve optimal success with 
avoiding bloodborne pathogens. Personal protective equipment refers to such supplies as 
disposable gloves, masks, eye wears, water resistant clothing covers in the way of gowns, shoe 
coverings, and head coverings. In most cases, not all of these sources of PPE need to be utilized 
at the same time, but it is imperative to know what and when to use the appropriate means of 
protection. Studies show support for when to wear different forms of PPE. For example, in a 
surgical setting “Evidence supports the use of double gloving and double gloving with an 
indicator glove system to decrease the risk of percutaneous injury and therefore is an effective 
barrier to bloodborne pathogen exposure” (Childs, 2013, pg. 586). While this may not be the 
case for every area of health care, it is a great example of how personal protective equipment 
provides an effective barrier against bloodborne pathogens.  
Universal precautions apply to multiple bodily fluids such as “blood, unfixed tissues, 
cerebrospinal fluid, synovial fluid, pleural fluid, peritoneal fluid, pericardial fluid, amniotic fluid, 
semen and vaginal secretions, nasal secretions, sputum, sweat, tears, urine, or vomitus” (Farlex 
Partner Medical Dictionary, 2012, paragraph 1). While universal precautions were created with 
health care workers in mind, they are a set of guidelines that can be applied to every person in 
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everyday life. Individuals who practice keeping themselves safe from all bodily fluids under all 
circumstances are most definitely less likely to contract bloodborne pathogens such as HIV, 
hepatitis B virus, and hepatitis c virus.  
 Another preventative method against bloodborne pathogens is abstinence. While some 
acknowledge abstinence in a negative mind-frame of self-deprivation, it is in fact the best 
prevention against bloodborne pathogens. Although there are other methods of contracting 
infectious diseases, sexual transmission is responsible for spreading the majority of bloodborne 
pathogens. Not only the act of sex, but also sexual favors and the number of sexual partners 
determines the increased risk an individual face.  
 Illicit drug use, while legally unacceptable, is also another highly responsible vector for 
transmission of bloodborne pathogens. As previously stated, needle sharing isn’t the only way 
for transmission to occur with drug use. It has also been proven that bloodborne pathogens can 
be contracted through indirect drug sharing and preparation practices, such as backloading and 
sharing cotton, also in the cooking process, and in the rinse water (Atler, 2007). Several areas 
nationally are taking a stand in the world of injection drug use to provide safer methods and 
supplies restrictions in order to reduce and prevent the spread of bloodborne pathogens. “Every 
state, the District of Columbia (DC), and The Virgin Islands (VI) have enacted state or local laws 
or regulations that restrict the sale, distribution, or possession of syringes. Drug paraphernalia 
laws prohibiting the sale, distribution, and/or possession of syringes known to be used to induce 
illicit drugs into the body exist in 47 states, DC, and VI. Syringe prescription laws prohibiting 
sale, distribution, and possession of syringes without a valid medical prescription exist in 8 states 
and VI. Pharmacy regulations or practice guidelines restrict access to syringes in 23 states” 
(Gostin, Lazzarini, Jones, & Flaherty, 1997, pg. 53). 
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 Other prevention methods might include new improved means of delivering “the 
message”, in other words, vamped up education could be a much-needed tool to influence the 
hard to reach population. Most individuals in today’s society don’t consider themselves “drug 
addicts”, they tend to view themselves as healthy and self-aware individuals which means there 
must be a different approach to delivering the message of bloodborne pathogens and safety. The 
idea of more discreate testing also helps reach those who feel they don’t have a problem with 
drug use (Bennett, 2015).  
Educational programs are another effective way to deliver insightful information to a 
mass crowd. In health care settings it isn’t uncommon to staff to do yearly continuing education 
units on different common areas for the staff. In those trainings, bloodborne pathogens are 
always a topic for coverage. It serves as a reminder to established staff and an educational tool to 
new and possibly unknowing staff of the severity of infectious diseases and the means necessary 
to protect one’s self in a health care setting. Many school systems also implement education 
courses on sexual activity, which include information on sexually transmitted infections and that 
opens a window to introduce the hazards of bloodborne pathogens in conjunctions with the 
importance of safe sex practices and the practice of abstinence. While it is important to error on 
the side of caution making sure the website is viable, reliable information, there are always good 
sources to be found online such as The Center for Disease Control and Prevention and The 
United States Department for Health and Human Services to name a couple. There is even a 
National HIV Testing Day that takes place on June 27 to raise awareness of the importance of 
prevention, detection and treatment. This is a nationwide day of awareness developed by the 
Center for Disease Control and Prevention (Stein, Song, et al, 2017) 
Legalities 
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 As touched on earlier in the writing, if an individual knowingly has HIV, hepatitis B, 
and/or hepatitis C virus, it is not only their due diligence to disclose that information to anyone 
who it might affect, but it is also the law. Sexual partners or potential sexual partners, health care 
workers, dentists, co-workers, and anyone that could possibly come in contact with any of the 
transmission vectors has the right to know if they are being put at risk of contracting a 
bloodborne pathogen. “During the early years of the HIV epidemic, a number of states 
implemented HIV-specific criminal exposure laws. These laws impose criminal penalties on 
people living with HIV who know their HIV status and who potentially expose others to HIV” 
(Center for Disease Control and Prevention, 2017, paragraph 1). These laws are taken very 
seriously, as exposing individuals to potentially fatal infectious disease is considered reckless 
endangerment and in some cases even more intense charges could occur, even attempted murder 
in some states. While most of the laws are state to state, some are federally instituted. “By 2011, 
a total of 67 laws explicitly focused on persons living with HIV had been enacted in 33 states. In 
24 states, laws require persons who are aware that they have HIV to disclose their status to 
sexual partners and 14 states require disclosure to needle-sharing partners. Twenty-five states 
criminalize one or more behaviors that pose a low or negligible risk for HIV transmission” 
(Center for Disease Control and Prevention, 2017, paragraph 3).  
 Provisions to protect health care workers from bloodborne pathogens began in California 
in 1998, these laws were specifically aimed at needlesticks in healthcare. By 2002 some twenty-
one states had jumped on board to develop new and improve old policies that protect against 
bloodborne pathogens in working healthcare professionals (Center for Disease Control and 
Prevention, 2016). “These state laws are aimed at adding additional safeguards for health care 
workers at the state level. This includes adding provisions not in the federal OSHA Bloodborne 
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Pathogen standard and/or coverage of public employees not regulated by OSHA” (Center for 
Disease Control and Prevention, 2016, paragraph 2).  
 While it is noted that some states need to update their statutes to accommodate to the new 
advances in drug therapy for HIV patients, Kentucky has already done such. Kentucky has also 
adjusted to include improvements made to hepatitis B and hepatitis C virus as well. In 
conjunction to individuals with infectious diseases disclosing that information, healthcare 
providers must also provide positive results for each bloodborne pathogens within a given 
amount of time. Providers must also include means for counseling services to be established and 
treatment to begin, all per state legislation.  
Conclusion 
 In conclusion, once again, bloodborne pathogens are tiny microorganisms that have 
multiple vectors of transmission which allow for more possibilities of contraction without 
preventative measures. The idea of self-awareness is so much more than just paying attention to 
detail. It could potentially be the future one faces if individuals fail to use protection, choose to 
abstain, and/or choose to practice good judgement. In a party time, care free life style, a “good 
time” could easily turn into a whole new world very quickly. And in a healthcare setting, 
carelessness can be critical for one’s self as well as for patient care. It is very important to follow 
all universal precaution policies put into place in order to decrease the likelihood of bloodborne 
pathogens spreading. Once again, bloodborne pathogens are not to be feared, but rather, well 
understood so that better precautions are taken under a multitude of circumstances. Life under 
the out from under the strong hold of bloodborne pathogens is almost always preventable and in 
such situations where it could not have been a choice, there are a new and developing treatments 
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